Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
A syndrome of marked fetal wastage is associated with congenital factor XIII deficiency in adult women. A previously unreported case of a woman with factor XIII deficiency is described, in which substitutive treatment with normal plasma or placental factor XIII concentrate permitted two normal pregnancies. Factor XIII activity was maintained above 1-2% with intermittent infusion of 300 ml to 450 ml of plasma every 14 days or of 500 units of concentrate every 21 days. This case confirms the only other case so far reported in which factor XIII substitutive therapy was able to permit a normal pregnancy in a woman with factor XIII deficiency and seems to suggest factor XIII to be involved in the process of annidation.
D000022:Abortion, Spontaneous / Q000517:prevention & control; D000328:Adult; D001803:Blood Transfusion; D005176:Factor XIII / Q000627:therapeutic use; D005177:Factor XIII Deficiency / Q000151:congenital* / Q000628:therapy; D005260:Female; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*
D005176:Factor XIII